Peripheral Neuropathies Derived from COVID-19: New Perspectives for Treatment
Peripheral neuropathies constitute a group of disorders affecting the peripheral nervous system. Neuropathies have multiple causes such as infections (i.e., COVID-19), diabetes, and nutritional (low vitamin levels), among others. Many micronutrients, such as vitamins (A, C, D, E, B6, B12, and folate...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/10/5/1051 |
_version_ | 1797501375706300416 |
---|---|
author | Alfredo Córdova-Martínez Alberto Caballero-García Daniel Pérez-Valdecantos Enrique Roche David César Noriega-González |
author_facet | Alfredo Córdova-Martínez Alberto Caballero-García Daniel Pérez-Valdecantos Enrique Roche David César Noriega-González |
author_sort | Alfredo Córdova-Martínez |
collection | DOAJ |
description | Peripheral neuropathies constitute a group of disorders affecting the peripheral nervous system. Neuropathies have multiple causes such as infections (i.e., COVID-19), diabetes, and nutritional (low vitamin levels), among others. Many micronutrients, such as vitamins (A, C, D, E, B6, B12, and folate), certain minerals (Fe, Mg, Zn, Se, and Cu), and ω-3 fatty acids have immunomodulatory effects. Therefore, they may play an instrumental role in the treatment of COVID-19 infection. However, many COVID-19 patients can undergo neuropathy. In this context, there is a wealth of information on a variety of first-, second-, and third-line treatment options. This review focuses on the application of nutraceutical strategies in order to improve the symptomatology of neuropathy and neuropathic pain in patients that suffered from COVID-19. Our aim is to provide an alternative vision to traditional medical-pharmacological treatment through nutraceuticals. |
first_indexed | 2024-03-10T03:17:30Z |
format | Article |
id | doaj.art-6d15b6d8150b45fa8f7c496bf7f89840 |
institution | Directory Open Access Journal |
issn | 2227-9059 |
language | English |
last_indexed | 2024-03-10T03:17:30Z |
publishDate | 2022-05-01 |
publisher | MDPI AG |
record_format | Article |
series | Biomedicines |
spelling | doaj.art-6d15b6d8150b45fa8f7c496bf7f898402023-11-23T10:10:19ZengMDPI AGBiomedicines2227-90592022-05-01105105110.3390/biomedicines10051051Peripheral Neuropathies Derived from COVID-19: New Perspectives for TreatmentAlfredo Córdova-Martínez0Alberto Caballero-García1Daniel Pérez-Valdecantos2Enrique Roche3David César Noriega-González4Department of Biochemistry, Molecular Biology and Physiology, Faculty of Health Sciences, GIR Physical Exercise and Aging, University of Valladolid, Campus Duques de Soria, 42004 Soria, SpainDepartment of Anatomy and Radiology, Faculty of Health Sciences, GIR Physical Exercise and Aging, University of Valladolid, Campus Duques de Soria, 42004 Soria, SpainDepartment of Biochemistry, Molecular Biology and Physiology, Faculty of Health Sciences, GIR Physical Exercise and Aging, University of Valladolid, Campus Duques de Soria, 42004 Soria, SpainDepartment of Applied Biology-Nutrition, Institute of Bioengineering, University Miguel Hernández, 03202 Elche, SpainDepartment of Surgery, Ophthalmology, Otorhinolaryngology and Physiotherapy, Faculty of Medicine, Hospital Clínico Universitario de Valladolid, 47005 Valladolid, SpainPeripheral neuropathies constitute a group of disorders affecting the peripheral nervous system. Neuropathies have multiple causes such as infections (i.e., COVID-19), diabetes, and nutritional (low vitamin levels), among others. Many micronutrients, such as vitamins (A, C, D, E, B6, B12, and folate), certain minerals (Fe, Mg, Zn, Se, and Cu), and ω-3 fatty acids have immunomodulatory effects. Therefore, they may play an instrumental role in the treatment of COVID-19 infection. However, many COVID-19 patients can undergo neuropathy. In this context, there is a wealth of information on a variety of first-, second-, and third-line treatment options. This review focuses on the application of nutraceutical strategies in order to improve the symptomatology of neuropathy and neuropathic pain in patients that suffered from COVID-19. Our aim is to provide an alternative vision to traditional medical-pharmacological treatment through nutraceuticals.https://www.mdpi.com/2227-9059/10/5/1051α-lipoic acidCOVID-19nutraceuticalsperipheral neuropathyvitamins |
spellingShingle | Alfredo Córdova-Martínez Alberto Caballero-García Daniel Pérez-Valdecantos Enrique Roche David César Noriega-González Peripheral Neuropathies Derived from COVID-19: New Perspectives for Treatment Biomedicines α-lipoic acid COVID-19 nutraceuticals peripheral neuropathy vitamins |
title | Peripheral Neuropathies Derived from COVID-19: New Perspectives for Treatment |
title_full | Peripheral Neuropathies Derived from COVID-19: New Perspectives for Treatment |
title_fullStr | Peripheral Neuropathies Derived from COVID-19: New Perspectives for Treatment |
title_full_unstemmed | Peripheral Neuropathies Derived from COVID-19: New Perspectives for Treatment |
title_short | Peripheral Neuropathies Derived from COVID-19: New Perspectives for Treatment |
title_sort | peripheral neuropathies derived from covid 19 new perspectives for treatment |
topic | α-lipoic acid COVID-19 nutraceuticals peripheral neuropathy vitamins |
url | https://www.mdpi.com/2227-9059/10/5/1051 |
work_keys_str_mv | AT alfredocordovamartinez peripheralneuropathiesderivedfromcovid19newperspectivesfortreatment AT albertocaballerogarcia peripheralneuropathiesderivedfromcovid19newperspectivesfortreatment AT danielperezvaldecantos peripheralneuropathiesderivedfromcovid19newperspectivesfortreatment AT enriqueroche peripheralneuropathiesderivedfromcovid19newperspectivesfortreatment AT davidcesarnoriegagonzalez peripheralneuropathiesderivedfromcovid19newperspectivesfortreatment |